Skip to main content
SpringerLink
Log in

Vascular Endothelial Growth Factor Receptor (VEGFR)

  • Living reference work entry
  • First Online:
Encyclopedia of Signaling Molecules

  • 74 Accesses

Synonyms

Vascular endothelial growth factor receptor 1 (VEGFR1): Fms-like tyrosine kinase 1 (FLT1); Tyrosine-protein kinase FRT; Tyrosine-protein kinase receptor FLT (FLT); Vascular permeability factor receptor.

Vascular endothelial growth factor receptor 2 (VEGFR2): Fetal liver kinase 1 (FLK1); Kinase insert domain receptor (KDR); Protein-tyrosine kinase receptor flk-1; CD_antigen (CD309).

Vascular endothelial growth factor receptor 3 (VEGFR3): Fms-like tyrosine kinase 4 (FLT4); Tyrosine-protein kinase receptor FLT4.

Historical Background

The vascular endothelial growth factor receptors (VEGFRs) are a family of receptor tyrosine kinases that mediate the biological functions of vascular endothelial growth factors (VEGFs), thereby playing key roles in vascular development. Following the discovery and cloning of VEGF, later denoted as VEGFA, as a potent inducer of vascular permeability and angiogenesis, VEGFR1 (alternatively denoted fms-like tyrosine kinase 1 (FLT1) in mouse) was first...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, Takeda A, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 2009;15(9):1023–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9(7):936–43.

    Article  CAS  PubMed  Google Scholar 

  • Calvo CF, Fontaine RH, Soueid J, Tammela T, Makinen T, Alfaro-Cervello C, et al. Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes Dev. 2011;25(8):831–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal. 2009;2(59):re1.

    Article  PubMed  Google Scholar 

  • Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coon BG, Baeyens N, Han J, Budatha M, Ross TD, Fang JS, et al. Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex. J Cell Biol. 2015;208(7):975–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dawson MR, Duda DG, Fukumura D, Jain RK. VEGFR1-activity-independent metastasis formation. Nature. 2009;461(7262):E4; discussion E5.

    Google Scholar 

  • de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255(5047):989–91.

    Article  PubMed  Google Scholar 

  • Deng Y, Zhang X, Simons M. Molecular controls of lymphatic VEGFR3 signaling. Arterioscler Thromb Vasc Biol. 2015;35(2):421–9.

    Article  CAS  PubMed  Google Scholar 

  • Dixelius J, Makinen T, Wirzenius M, Karkkainen MJ, Wernstedt C, Alitalo K, et al. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem. 2003;278(42):40973–9.

    Article  CAS  PubMed  Google Scholar 

  • Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998;282(5390):946–9.

    Article  CAS  PubMed  Google Scholar 

  • Gordon EJ, Fukuhara D, Westrom S, Padhan N, Sjostrom EO, van Meeteren L, et al. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation. Sci Signal. 2016;9(437):ra72.

    Article  PubMed  Google Scholar 

  • Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464(7290):917–21.

    Article  CAS  PubMed  Google Scholar 

  • Han J, Calvo CF, Kang TH, Baker KL, Park JH, Parras C, et al. Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans. Cell Rep. 2015;10(7):1158–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal. 2007;19(10):2003–12.

    Article  CAS  PubMed  Google Scholar 

  • Jakobsson L, Kreuger J, Holmborn K, Lundin L, Eriksson I, Kjellen L, et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006;10(5):625–34.

    Article  CAS  PubMed  Google Scholar 

  • Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell. 2012;151(2):384–99.

    Article  CAS  PubMed  Google Scholar 

  • Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med. 1993;178(6):2077–88.

    Article  CAS  PubMed  Google Scholar 

  • Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74–80.

    Article  CAS  PubMed  Google Scholar 

  • Kendall RL, Rutledge RZ, Mao X, Tebben AJ, Hungate RW, Thomas KA. Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J Biol Chem. 1999;274(10):6453–60.

    Article  CAS  PubMed  Google Scholar 

  • Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2012;2(7):a006502.

    Article  PubMed  PubMed Central  Google Scholar 

  • Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437(2):169–83.

    Article  CAS  PubMed  Google Scholar 

  • Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7(2):199–205.

    Article  CAS  PubMed  Google Scholar 

  • Mendola A, Schlogel MJ, Ghalamkarpour A, Irrthum A, Nguyen HL, Fastre E, et al. Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema. Mol Syndromol. 2013;4(6):257–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Planas-Paz L, Strilic B, Goedecke A, Breier G, Fassler R, Lammert E. Mechanoinduction of lymph vessel expansion. EMBO J. 2012;31(4):788–804.

    Article  CAS  PubMed  Google Scholar 

  • Robciuc MR, Kivela R, Williams IM, de Boer JF, van Dijk TH, Elamaa H, et al. VEGFB/VEGFR1-induced expansion of adipose vasculature counteracts obesity and related metabolic complications. Cell Metab. 2016;23(4):712–24.

    Article  CAS  PubMed  Google Scholar 

  • Roskoski Jr R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol. 2007;62(3):179–213.

    Article  PubMed  Google Scholar 

  • Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci U S A. 2005;102(4):1076–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Selvaraj D, Gangadharan V, Michalski CW, Kurejova M, Stosser S, Srivastava K, et al. A functional role for VEGFR1 expressed in peripheral sensory neurons in cancer pain. Cancer Cell. 2015;27(6):780–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376(6535):62–6.

    Article  CAS  PubMed  Google Scholar 

  • Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2(12):1097–105.

    Article  PubMed  PubMed Central  Google Scholar 

  • Simons M. An inside view: VEGF receptor trafficking and signaling. Physiology (Bethesda). 2012;27(4):213–22.

    Article  CAS  Google Scholar 

  • Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17(10):611–25.

    Article  CAS  PubMed  Google Scholar 

  • Takahashi T, Yamaguchi S, Chida K, Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 2001;20(11):2768–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tammela T, Zarkada G, Nurmi H, Jakobsson L, Heinolainen K, Tvorogov D, et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol. 2011;13(10):1202–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992;187(3):1579–86.

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Zhou F, Han W, Shen B, Luo J, Shibuya M, et al. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 2010;20(12):1319–31.

    Article  CAS  PubMed  Google Scholar 

  • Zhou F, Chang Z, Zhang L, Hong YK, Shen B, Wang B, et al. Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am J Pathol. 2010;177(4):2124–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185, Uppsala, Sweden

    Roberta Lugano, Hua Huang & Anna Dimberg

Authors
  1. Roberta Lugano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hua Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Dimberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Dimberg .

Editor information

Editors and Affiliations

  1. Dept. Biological Science, Department of Molecular Science and Tech College of Natural Science, Suwon, Korea (Republic of)

    Sangdun Choi

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this entry

Cite this entry

Lugano, R., Huang, H., Dimberg, A. (2016). Vascular Endothelial Growth Factor Receptor (VEGFR). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6438-9_101914-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6438-9_101914-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6438-9

  • Online ISBN: 978-1-4614-6438-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation